Journal of Hematopathology

Aims & Scope

The Journal of Hematopathology aims at providing pathologists with a special interest in hematopathology with all the information needed to perform modern pathology in evaluating lymphoid tissues and bone marrow.

To this end the journal publishes reviews, editorials, comments, original papers, guidelines and protocols, papers on ancillary techniques, and occasional case reports in the fields of the pathology, molecular biology, and clinical features of diseases of the hematopoietic system.

The journal is the unique reference point for all pathologists with an interest in hematopathology.

Molecular biologists involved in the expanding field of molecular diagnostics and research on lymphomas and leukemia benefit from the journal, too.

Furthermore, the journal is of major interest for hematologists dealing with patients suffering from lymphomas, leukemias, and other diseases.

The journal is unique in its true international character.

Especially in the field of hematopathology it is clear that there are huge geographical variations in incidence of diseases.

This is not only locally relevant, but due to globalization, relevant for all those involved in the management of patients.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	0.6
2024	0.60

SJR (SCImago Journal Rank)

Year	Value
2024	0.171

Quartile

Year	Value
2024	Q4

h-index

Year	Value
2024	21

Journal Rank

Year	Value
2024	23062

Journal Citation Indicator

Year	Value
2024	57

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Ki-67 as a prognostic marker in mantle cell lymphoma—consensus guidelines of the pathology panel of the European MCL Network

  Citation: 134

  Authors: Wolfram, Eva, Olaf, Ilske, Jeroen, Françoise, Heinz Wolfram, José, Elias, Sergio, Martin Leo, Philip M., Roman, Yuri A., Christoph, Harald, Peter, Thomas E. F., Konrad, Andreas, German, Stefano, Elisabeth, Grzegorz, Johan H., Hans Heinrich, Michael, Wolfgang, Martin

• Gray zones around diffuse large B cell lymphoma. Conclusions based on the workshop of the XIV meeting of the European Association for Hematopathology and the Society of Hematopathology in Bordeaux, France

  Citation: 69

  Authors: Leticia, Daphne, Antoine, Eric D., Philip, Yaso, Marie, Stefano, German

• Novel developments in the pathogenesis and diagnosis of extranodal marginal zone lymphoma

  Citation: 53

  Authors: Max I., Michiel, Konnie M., Patricia J. T. A., J. Han, Blanca

• Commentary on the WHO classification of tumors of lymphoid tissues (2008): “Gray zone” lymphomas overlapping with Burkitt lymphoma or classical Hodgkin lymphoma

  Citation: 50

  Authors: Robert P., German, Kojo S. J., Olga, Daphne, Laurence

• Commentary on the 2008 WHO classification of mature T- and NK-cell neoplasms

  Citation: 44

  Authors: Megan S., Laurence, Leticia

• Myeloproliferative neoplasms in children

  Citation: 43

  Authors: Inga

• Rare lymphoid malignancies of the breast: a report of two cases illustrating potential diagnostic pitfalls

  Citation: 40

  Authors: Evan A., Judith A., Nancy Lee, Ephraim P., Ronald W., Dan S., Aliyah R.

• Epstein–Barr virus-associated inflammatory pseudotumor of the spleen: report of two cases and review of the literature

  Citation: 35

  Authors: Lizabeth, M. Houman, Ian, Mohammad A.

• Multiple clonal Ig/TCR products: implications for interpretation of clonality findings

  Citation: 30

  Authors: Anton W., Jacques J. M.

• Early lesions in lymphoid neoplasia

  Citation: 27

  Authors: Falko, José, Philippe, Elaine S., Philip, Isinsu, LoAnn, Andrew, Christer

---